US86881A1007
US86881A1007
Surgery Partners, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.82B EUR | 2.2B EUR | 1.56B EUR | 2B EUR |
Enterprise Value | 7.42B EUR | 6.04B EUR | 5.4B EUR | 5.78B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 49.61x | -- | -- | -- |
Price to Sales | 0.54x | 0.65x | 0.47x | 0.79x |
Price to Book | 1.08x | 1.32x | 0.92x | 1.17x |
EV/Revenue | 2.2x | 1.79x | 1.62x | 2.28x |
EV/EBITDA | 11.48x | 9.03x | 8.02x | 10.57x |
Price to FCF (P/FCF) | 9.91x | 11.72x | 7.5x | 9.41x |
EV/FCF | 40.41x | 32.2x | 25.98x | 27.24x |
FCF Yield | 10.09% | 8.53% | 13.34% | 10.63% |